Europe Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

Europe oncology informatics market accounted for USD 1,199.6 million in 2019 and will grow by 5.0% annually over 2020-2030 owing to the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates.

Highlighted with 37 tables and 47 figures, this 114-page report Europe Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Europe oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Country.

Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Electronic Health Records (EHRs)

Population Health Management (PHM)

Clinical Decision Support System (CDSS)

Drug Discovery and Development Informatics (DDDI)

Data Analytics

Image Analytics

Other Product Types

Based on Cancer Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Colorectal Cancer

Breast Cancer

Prostate Cancer

Cervical Cancer

Other Cancers

Based on Application, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Medical Application

Surgical Application

Radiation Application

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Pharmaceutical Companies

Life Science Companies

Contract Research Organizations (CROs)

Academic Institutes and Research Centers

Other End Users

Geographically, the following national/local markets are fully investigated:

Germany

UK

France

Spain

Italy

Russia

Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Europe oncology informatics market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Cerner Corporation

Change Healthcare

Elekta AB

F.Hoffmann-La Roche Ltd.

Hologic Inc.

IBM Corporation

Inspirata Inc.

Koninklijke Philips N.V.

Laboratory Corporation of America Holdings

McKesson Corporation

MIM Software, Inc.

Oncology Analytics, Inc

PerkinElmer, Inc.

RELX Group

Sirenas, LLC

UnitedHealth Group, Inc

Varian Medical Systems, Inc

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Cerner Corporation

Change Healthcare

Elekta AB

F.Hoffmann-La Roche Ltd.

Hologic Inc.

IBM Corporation

Inspirata Inc.

Koninklijke Philips N.V.

Laboratory Corporation of America Holdings

McKesson Corporation

MIM Software, Inc.

Oncology Analytics, Inc

PerkinElmer, Inc.

RELX Group

Sirenas, LLC

UnitedHealth Group, Inc

Varian Medical Systems, Inc

Table of Contents

Table of Contents

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 14

1.2.6 Market Size/Share Estimation 15

1.2.7 Research Limitations 16

1.3 Executive Summary 17

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.1.1 Impact of COVID-19 on the Market 21

2.2 Major Growth Drivers 23

2.3 Market Restraints and Challenges 26

2.4 Emerging Opportunities and Market Trends 29

2.5 Porter's Fiver Forces Analysis 33

3 Segmentation of Europe Market by Product Type 37

3.1 Market Overview by Product Type 37

3.2 Electronic Health Records (EHRs) 39

3.3 Population Health Management (PHM) 41

3.4 Clinical Decision Support System (CDSS) 43

3.5 Drug Discovery and Development Informatics (DDDI) 45

3.6 Data Analytics 47

3.7 Image Analytics 48

3.8 Other Product Types 49

4 Segmentation of Europe Market by Cancer Type 50

4.1 Market Overview by Cancer Type 50

4.2 Colorectal Cancer 52

4.3 Breast Cancer 53

4.4 Prostate Cancer 54

4.5 Cervical Cancer 55

5 Segmentation of Europe Market by Application 56

5.1 Market Overview by Application 56

5.2 Medical Application 58

5.3 Surgical Application 59

5.4 Radiation Application 60

6 Segmentation of Europe Market by End User 62

6.1 Market Overview by End User 62

6.2 Pharmaceutical Companies 64

6.3 Life Science Companies 65

6.4 Contract Research Organizations (CROs) 66

6.5 Academic Institutes and Research Centers 67

6.6 Other End Users 68

7 European Market 2019-2030 by Country 69

7.1 Overview of European Market 69

7.2 Germany 72

7.3 UK 74

7.4 France 76

7.5 Spain 78

7.6 Italy 80

7.7 Russia 82

7.8 Rest of European Market 84

8 Competitive Landscape 86

8.1 Overview of Key Vendors 86

8.2 New Product Launch, Partnership, Investment, and M&A 89

8.3 Company Profiles 90

Cerner Corporation 90

Change Healthcare 92

Elekta AB 93

F.Hoffmann-La Roche Ltd. 94

Hologic Inc. 95

IBM Corporation 96

Inspirata Inc. 97

Koninklijke Philips N.V. 98

Laboratory Corporation of America Holdings 99

McKesson Corporation 100

MIM Software, Inc. 101

Oncology Analytics, Inc 102

PerkinElmer, Inc. 103

RELX Group 104

Sirenas, LLC 105

UnitedHealth Group, Inc 106

Varian Medical Systems, Inc 107

9 Investing in Europe Market: Risk Assessment and Management 108

9.1 Risk Evaluation of Europe Market 108

9.2 Critical Success Factors (CSFs) 111

Related Reports and Products 114


List of Figure

Figure 1. Research Method Flow Chart 11

Figure 2. Breakdown of Primary Research 13

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15

Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17

Figure 5. Europe Oncology Informatics Market, 2019-2030, USD mn 20

Figure 6. Impact of COVID-19 on Business 21

Figure 7. Primary Drivers and Impact Factors of Europe Oncology Informatics Market 23

Figure 8. Primary Restraints and Impact Factors of Europe Oncology Informatics Market 26

Figure 9. Investment Opportunity Analysis 30

Figure 10. Porter's Fiver Forces Analysis of Europe Oncology Informatics Market 33

Figure 11. Breakdown of Europe Oncology Informatics Market by Product Type, 2019-2030, % of Revenue 38

Figure 12. Europe Addressable Market Cap in 2020-2030 by Product Type, Value (USD mn) and Share (%) 38

Figure 13. Europe Oncology Informatics Market: Electronic Health Records (EHRs), 2019-2030, USD mn 39

Figure 14. Europe Oncology Informatics Market: Population Health Management (PHM), 2019-2030, USD mn 41

Figure 15. Europe Oncology Informatics Market: Clinical Decision Support System (CDSS), 2019-2030, USD mn 43

Figure 16. Europe Oncology Informatics Market: Drug Discovery and Development Informatics (DDDI), 2019-2030, USD mn 45

Figure 17. Europe Oncology Informatics Market: Data Analytics, 2019-2030, USD mn 47

Figure 18. Europe Oncology Informatics Market: Image Analytics, 2019-2030, USD mn 48

Figure 19. Europe Oncology Informatics Market: Other Product Types, 2019-2030, USD mn 49

Figure 20. Breakdown of Europe Oncology Informatics Market by Cancer Type, 2019-2030, % of Sales Revenue 50

Figure 21. Europe Addressable Market Cap in 2020-2030 by Cancer Type, Value (USD mn) and Share (%) 51

Figure 22. Europe Oncology Informatics Market: Colorectal Cancer, 2019-2030, USD mn 52

Figure 23. Europe Oncology Informatics Market: Breast Cancer, 2019-2030, USD mn 53

Figure 24. Europe Oncology Informatics Market: Prostate Cancer, 2019-2030, USD mn 54

Figure 25. Europe Oncology Informatics Market: Cervical Cancer, 2019-2030, USD mn 55

Figure 26. Breakdown of Europe Oncology Informatics Market by Application, 2019-2030, % of Sales Revenue 56

Figure 27. Europe Addressable Market Cap in 2020-2030 by Application, Value (USD mn) and Share (%) 57

Figure 28. Europe Oncology Informatics Market: Medical Application, 2019-2030, USD mn 58

Figure 29. Europe Oncology Informatics Market: Surgical Application, 2019-2030, USD mn 59

Figure 30. Europe Oncology Informatics Market: Radiation Application, 2019-2030, USD mn 60

Figure 31. Breakdown of Europe Oncology Informatics Market by End User, 2019-2030, % of Revenue 62

Figure 32. Europe Addressable Market Cap in 2020-2030 by End User, Value (USD mn) and Share (%) 63

Figure 33. Europe Oncology Informatics Market: Pharmaceutical Companies, 2019-2030, USD mn 64

Figure 34. Europe Oncology Informatics Market: Life Science Companies, 2019-2030, USD mn 65

Figure 35. Europe Oncology Informatics Market: Contract Research Organizations (CROs), 2019-2030, USD mn 66

Figure 36. Europe Oncology Informatics Market: Academic Institutes and Research Centers, 2019-2030, USD mn 67

Figure 37. Europe Oncology Informatics Market: Other End Users, 2019-2030, USD mn 68

Figure 38. Breakdown of European Oncology Informatics Market by Country, 2019 and 2030, % of Revenue 70

Figure 39. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 71

Figure 40. Oncology Informatics Market in Germany, 2019-2030, USD mn 72

Figure 41. Oncology Informatics Market in UK, 2019-2030, USD mn 74

Figure 42. Oncology Informatics Market in France, 2019-2030, USD mn 76

Figure 43. Oncology Informatics Market in Spain, 2019-2030, USD mn 78

Figure 44. Oncology Informatics Market in Italy, 2019-2030, USD mn 80

Figure 45. Oncology Informatics Market in Russia, 2019-2030, USD mn 82

Figure 46. Oncology Informatics Market in Rest of Europe, 2019-2030, USD mn 84

Figure 47. Growth Stage of Europe Oncology Informatics Industry over the Forecast Period 86


List of Table

Table 1. Snapshot of Europe Oncology Informatics Market, 2019-2030 18

Table 2. Main Product Trends and Market Opportunities in Europe Oncology Informatics Market 29

Table 3. Europe Oncology Informatics Market by Product Type, 2019-2030, USD mn 37

Table 4. Key Products and EHR Vendors 40

Table 5. Key Products and PHM Vendors 42

Table 6. Key Products and CDSS Vendors 44

Table 7. Key Products and DDDI Vendors 46

Table 8. Europe Oncology Informatics Market by Cancer Type, 2019-2030, USD mn 50

Table 9. Europe Oncology Informatics Market by Application, 2019-2030, USD mn 56

Table 10. Europe Oncology Informatics Market by End User, 2019-2030, USD mn 62

Table 11. Europe Oncology Informatics Market by Country, 2019-2030, USD mn 71

Table 12. Germany Oncology Informatics Market by Product Type, 2019-2030, USD mn 73

Table 13. Germany Oncology Informatics Market by Cancer Type, 2019-2030, USD mn 73

Table 14. Germany Oncology Informatics Market by End User, 2019-2030, USD mn 73

Table 15. UK Oncology Informatics Market by Product Type, 2019-2030, USD mn 75

Table 16. UK Oncology Informatics Market by Cancer Type, 2019-2030, USD mn 75

Table 17. UK Oncology Informatics Market by End User, 2019-2030, USD mn 75

Table 18. France Oncology Informatics Market by Product Type, 2019-2030, USD mn 77

Table 19. France Oncology Informatics Market by Cancer Type, 2019-2030, USD mn 77

Table 20. France Oncology Informatics Market by End User, 2019-2030, USD mn 77

Table 21. Spain Oncology Informatics Market by Product Type, 2019-2030, USD mn 79

Table 22. Spain Oncology Informatics Market by Cancer Type, 2019-2030, USD mn 79

Table 23. Spain Oncology Informatics Market by End User, 2019-2030, USD mn 79

Table 24. Italy Oncology Informatics Market by Product Type, 2019-2030, USD mn 81

Table 25. Italy Oncology Informatics Market by Cancer Type, 2019-2030, USD mn 81

Table 26. Italy Oncology Informatics Market by End User, 2019-2030, USD mn 81

Table 27. Russia Oncology Informatics Market by Product Type, 2019-2030, USD mn 83

Table 28. Russia Oncology Informatics Market by Cancer Type, 2019-2030, USD mn 83

Table 29. Russia Oncology Informatics Market by End User, 2019-2030, USD mn 83

Table 30. Oncology Informatics Market in Rest of Europe by Country, 2019-2030, USD mn 85

Table 31. Cerner Corporation: Company Snapshot 90

Table 32. Cerner Corporation: Business Segmentation 90

Table 33. Cerner Corporation: Product Portfolio 91

Table 34. Cerner Corporation: Revenue, 2016-2018, USD mn 91

Table 35. Cerner Corporation: Recent Developments 91

Table 36. Risk Evaluation for Investing in Europe Market, 2019-2030 109

Table 37. Critical Success Factors and Key Takeaways 112

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us